Eco R1 Capital, LLC Gritstone Bio, Inc. Transaction History

Eco R1 Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.03 - $12.19 $24.2 Million - $73.3 Million	-6,012,232 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.76 - $13.71 $3.95 Million - $6.19 Million	451,484 Added 8.12%	6,012,232 $77.3 Million
Q3 2021 Nov 15, 2021	BUY	$6.41 - $13.54 $13.7 Million - $29 Million	2,139,461 Added 62.53%	5,560,748 $60.1 Million
Q4 2020 Feb 16, 2021	BUY	$2.57 - $4.22 $8.79 Million - $14.4 Million	3,421,287 New	3,421,287 $13.5 Million

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.